Sign In

Katie Sullivan

Associate Director, Clinical Manufacturing at 4D Molecular Therapeutics

Professional Background

Katie Sullivan is a highly versatile chemical engineer with an impressive background in biopharma manufacturing and analytical biotechnology research. With substantial experience in both large pharmaceutical companies and dynamic biotech startups, Katie has made significant contributions throughout her career, particularly in the field of chemistry and engineering in healthcare applications.

Her career at 4D Molecular Therapeutics exemplifies her ability to adapt and excel in diverse roles within the clinical manufacturing sector. Katie initially joined the company as an Associate Scientist in Process Development and progressively ascended through various positions including Supervisor and Manager of Clinical Manufacturing, ultimately becoming the Associate Director. Her journey at 4D Molecular Therapeutics highlights her expertise in advancing early process development and establishing Good Manufacturing Practice (GMP) for complex biopharmaceuticals.

In addition to her technical roles, Katie has dedicated herself to the promotion and support of women in science as President of the Association for Women in Science (AWIS) East Bay chapter. This leadership position enables her to advocate for gender equality in STEM fields and mentor young women pursuing careers in scientific and engineering disciplines.

Education and Achievements

Katie holds a Bachelor of Science in Chemical Engineering with Honors from the prestigious Stanford University, where she developed a strong foundation in the principles of chemical engineering. Continuing her education, she earned two Master's degrees in Translational Medicine from the University of California, Berkeley, and from the University of California, San Francisco. This specialized education prepared her to work at the intersection of engineering and medicine, equipping her to lead innovative projects in biopharma development.

Katie began her career at Merck, where she gained valuable experience as a Process Engineer and was part of the Manufacturing Division Rotation Analyst program. Her initial experiences in one of the top pharmaceutical companies allowed her to hone her skills in manufacturing processes, ultimately contributing to her deep understanding of biopharmaceutical production.

Following her initial experiences in industry, Katie transitioned to biotechnology research with a research position at UCSF’s Helen Diller Family Comprehensive Cancer Center in the Munster Lab. This role further cemented her expertise in process development and research methodologies, underpinning her journey into the biotech sector.

Achievements

Katie's notable achievements include her rapid advancement in 4D Molecular Therapeutics, where her leadership and innovation have fostered significant developments in clinical manufacturing operations. By bridging the gap between research and application, she has demonstrated her ability to manage projects that bring cutting-edge therapies to market. This contribution is critical in a field where timely development and rigorous standards are paramount.

Her commitment to supporting underrepresented professionals in the sciences through her work with the Association for Women in Science has also made a notable impact throughout her career. Under her guidance, the East Bay chapter has sought to empower women, fostering an inclusive environment that is essential for the future of STEM fields.

Through her multifaceted roles and dedication to improving biopharma manufacturing processes, Katie Sullivan continues to be an influential figure in chemical engineering and biotechnology, driving innovation and advocate for women in science.

Related Questions

How did Katie Sullivan's education at Stanford University prepare her for her career in chemical engineering?
What motivated Katie Sullivan to support women in science through her role as President of the AWIS East Bay chapter?
Can Katie Sullivan share more about her experiences in transitioning from a large pharmaceutical company to a biotech startup?
In what ways has Katie Sullivan contributed to advancements in clinical manufacturing at 4D Molecular Therapeutics?
What challenges has Katie Sullivan faced in her roles within the biotech industry, and how has she overcome them?
Katie Sullivan
Add to my network

Location

San Francisco Bay Area